Sanofi Completes Acquisition of Bioverativ Inc.

Bioverativ Inc. is a fully owned subsidiary of Sanofi

Paris (France) - March 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sanofi announced today the successful completion of its acquisition of Bioverativ Inc. ("Bioverativ") for $105 pe... Biopharmaceuticals, Mergers & Acquisitions Sanofi, Bioverativ, hemophilia

Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news